Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

cyber- security firm has "warned hackers have broken into real news websites and posted fake stories stirring up anti- NATO sentiment." According to FireEye researchers, "the disinformation campaign, nicknamed `ghostwriter,' has been ongoing since 2017." They "said that it is designed to `chip away' at s

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

k." The panel previously received "a closed-door briefing about the incident from the NSA, the FBI, CISA and ODNI, and held an informal session with FireEye CEO Kevin Mandia, whose company discovered the compromise." Mandia will appear "before the committee again tomorrow, along with Sudhakar Ramakrishn

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

mrenkes to justice." CYBER DIVISION How The SolarWinds Hack Happened. CNBC (1/26, 7.34M) reports in a video that, "in December, cybersecurity firm FireEye discovered that it had been compromised by a sophisticated hack." SolarWinds, an IT firm that FireEye used, "was the victim of a supply-chain attac

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

cyber-security firm has "warned hackers have broken into real news websites and posted fake stories stirring up anti-NATO sentiment." According to FireEye researchers, "the disinformation campaign, nicknamed 'ghostwriter,' has been ongoing since 2017." They "said that it is designed to 'chip away' at s

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

cyber-security firm has "warned hackers have broken into real news websites and posted fake stories stirring up anti-NATO sentiment." According to FireEye researchers, "the disinformation campaign, nicknamed `ghostwriter' has been ongoing since 2017." They "said that it is designed to `chip away' at su